ES2492681T3 - Método cromatográfico para purificar proteínas que contienen FC - Google Patents
Método cromatográfico para purificar proteínas que contienen FC Download PDFInfo
- Publication number
- ES2492681T3 ES2492681T3 ES11700457.2T ES11700457T ES2492681T3 ES 2492681 T3 ES2492681 T3 ES 2492681T3 ES 11700457 T ES11700457 T ES 11700457T ES 2492681 T3 ES2492681 T3 ES 2492681T3
- Authority
- ES
- Spain
- Prior art keywords
- protein
- concentration
- sought
- mobile phase
- stationary phase
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
- C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
Abstract
Método para disminuir las impurezas de una composición que contiene una proteína con el dominio Fc de una inmunoglobulina (proteína buscada) mediante una cromatografía de proteína A que consta de las siguientes etapas: a) uso de una fase móvil que contiene la proteína buscada sobre una fase estacionaria que lleva la proteína A, en unas condiciones en que la proteína buscada se fija a la fase estacionaria; b) uso de un tampón de lavado con un pH comprendido entre 5 y 8 como fase móvil, que lleva como aditivos i) arginina a una concentración de 0,1 - 1 mol/l, ii) cloruro sódico a una concentración de 0,2 hasta 2 mol/l, iii) un alcohol elegido del grupo formado por isopropanol, n-propanol y etanol a una concentración del 5 - 30% (p/v) y iv) polivinilpirrolidona o un detergente a una concentración del 0,05 - 2% (p/v); c) uso de un tampón de elución como fase móvil, en unas condiciones en que la proteína buscada es eluida de la fase estacionaria.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP10151416 | 2010-01-22 | ||
| EP10151416 | 2010-01-22 | ||
| EP10171975 | 2010-08-05 | ||
| EP10171975 | 2010-08-05 | ||
| PCT/EP2011/050817 WO2011089212A1 (de) | 2010-01-22 | 2011-01-21 | Chromatographisches verfahren zur aufreinigung von fc enthaltenden proteinen |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2492681T3 true ES2492681T3 (es) | 2014-09-10 |
Family
ID=43598239
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES11700457.2T Active ES2492681T3 (es) | 2010-01-22 | 2011-01-21 | Método cromatográfico para purificar proteínas que contienen FC |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9284347B2 (es) |
| EP (1) | EP2526114B1 (es) |
| JP (1) | JP5567691B2 (es) |
| KR (1) | KR101753569B1 (es) |
| CN (1) | CN102712673B (es) |
| AU (1) | AU2011208659B2 (es) |
| CA (1) | CA2784959C (es) |
| DK (1) | DK2526114T3 (es) |
| ES (1) | ES2492681T3 (es) |
| HK (1) | HK1174044A1 (es) |
| SG (1) | SG182553A1 (es) |
| WO (1) | WO2011089212A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ602971A (en) * | 2010-04-23 | 2014-11-28 | Serum Inst India Ltd | Simple method for simultaneous removal of multiple impurities from culture supernatants to ultralow levels |
| CA2834300C (en) * | 2011-06-01 | 2022-01-11 | Novartis Ag | Wash solution and method for affinity chromatography |
| RU2646098C2 (ru) | 2013-04-30 | 2018-03-01 | Интас Фармасьютикалс Лтд | Новый способ клонирования, экспрессии и очистки для получения ранибизумаба |
| AR096713A1 (es) | 2013-06-25 | 2016-01-27 | Cadila Healthcare Ltd | Proceso de purificación para anticuerpos monoclonales |
| BR112016029157A8 (pt) * | 2014-06-13 | 2021-07-06 | Lupin Ltd | processo para purificar a proteína de fusão tnfr:fc |
| US11566082B2 (en) | 2014-11-17 | 2023-01-31 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| AU2015372801B2 (en) | 2014-12-31 | 2018-12-20 | Lg Chem, Ltd. | Method for preparing tnfr-fc fusion protein containing target content of impurities |
| US10654887B2 (en) | 2016-05-11 | 2020-05-19 | Ge Healthcare Bio-Process R&D Ab | Separation matrix |
| US10730908B2 (en) | 2016-05-11 | 2020-08-04 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US11753438B2 (en) | 2016-05-11 | 2023-09-12 | Cytiva Bioprocess R&D Ab | Method of cleaning and/or sanitizing a separation matrix |
| US10889615B2 (en) | 2016-05-11 | 2021-01-12 | Cytiva Bioprocess R&D Ab | Mutated immunoglobulin-binding polypeptides |
| WO2017194592A1 (en) | 2016-05-11 | 2017-11-16 | Ge Healthcare Bioprocess R&D Ab | Method of storing a separation matrix |
| US10703774B2 (en) | 2016-09-30 | 2020-07-07 | Ge Healthcare Bioprocess R&D Ab | Separation method |
| US10513537B2 (en) | 2016-05-11 | 2019-12-24 | Ge Healthcare Bioprocess R&D Ab | Separation matrix |
| WO2019096777A1 (en) * | 2017-11-14 | 2019-05-23 | Bio-Sourcing S.A. | Antibody purification |
| EP3546475A1 (en) * | 2018-03-27 | 2019-10-02 | Sanofi | Full flow-through process for purifying recombinant proteins |
| CN113166200B (zh) * | 2018-12-21 | 2024-03-01 | 上海药明生物技术有限公司 | 一种提高蛋白a层析法去除聚集体的方法 |
| CN111333776B (zh) * | 2020-03-20 | 2021-11-09 | 暨南大学 | 一种氮杂环类有机聚合物整体材料及制备与应用 |
| WO2024017826A2 (en) * | 2022-07-19 | 2024-01-25 | Glaxosmithkline Intellectual Property Development Limited | Methods for purifying recombinant polypeptides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5874218A (en) * | 1990-06-11 | 1999-02-23 | Nexstar Pharmaceuticals, Inc. | Method for detecting a target compound in a substance using a nucleic acid ligand |
| US5585246A (en) * | 1993-02-17 | 1996-12-17 | Biometric Imaging, Inc. | Method for preparing a sample in a scan capillary for immunofluorescent interrogation |
| ATE417858T1 (de) | 2002-02-05 | 2009-01-15 | Genentech Inc | Proteinaufreinigung |
| US8084032B2 (en) * | 2004-01-21 | 2011-12-27 | Ajinomoto Co., Inc. | Purification method which prevents denaturation of an antibody |
| WO2007059473A2 (en) * | 2005-11-12 | 2007-05-24 | Introgen Therapeutics, Inc. | Methods for the production and purification of adenoviral vectors |
| AU2007204987B2 (en) | 2006-01-06 | 2011-11-24 | Amgen Inc. | Methods and systems for isolating target molecules from complex solutions by column-chromatography using eluants containing organic solvents |
| US8263750B2 (en) | 2006-03-16 | 2012-09-11 | Amgen Inc. | Method for purifying a protein using protein-A affinity chromatography using an intermediate wash step |
| TW200821026A (en) * | 2006-09-08 | 2008-05-16 | Wyeth Corp | Arginine wash in protein purification using affinity chromatography |
| CA2751000A1 (en) * | 2009-03-11 | 2010-12-23 | Wyeth Llc | Methods of purifying small modular immunopharmaceutical proteins |
| WO2011073389A1 (en) | 2009-12-18 | 2011-06-23 | Novartis Ag | Wash solution and method for affinity chromatography |
-
2011
- 2011-01-21 CN CN201180006652.0A patent/CN102712673B/zh active Active
- 2011-01-21 JP JP2012549368A patent/JP5567691B2/ja active Active
- 2011-01-21 KR KR1020127019071A patent/KR101753569B1/ko active IP Right Grant
- 2011-01-21 US US13/522,030 patent/US9284347B2/en active Active
- 2011-01-21 ES ES11700457.2T patent/ES2492681T3/es active Active
- 2011-01-21 AU AU2011208659A patent/AU2011208659B2/en active Active
- 2011-01-21 WO PCT/EP2011/050817 patent/WO2011089212A1/de active Application Filing
- 2011-01-21 SG SG2012052452A patent/SG182553A1/en unknown
- 2011-01-21 DK DK11700457.2T patent/DK2526114T3/da active
- 2011-01-21 CA CA2784959A patent/CA2784959C/en active Active
- 2011-01-21 EP EP11700457.2A patent/EP2526114B1/de active Active
-
2013
- 2013-01-23 HK HK13101026.1A patent/HK1174044A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP5567691B2 (ja) | 2014-08-06 |
| KR20120118013A (ko) | 2012-10-25 |
| DK2526114T3 (da) | 2014-09-29 |
| EP2526114A1 (de) | 2012-11-28 |
| CN102712673B (zh) | 2014-04-30 |
| CA2784959C (en) | 2018-06-26 |
| JP2013517318A (ja) | 2013-05-16 |
| US20130197197A1 (en) | 2013-08-01 |
| AU2011208659B2 (en) | 2015-05-28 |
| WO2011089212A1 (de) | 2011-07-28 |
| SG182553A1 (en) | 2012-08-30 |
| CA2784959A1 (en) | 2011-07-28 |
| HK1174044A1 (en) | 2013-05-31 |
| AU2011208659A1 (en) | 2012-07-19 |
| KR101753569B1 (ko) | 2017-07-04 |
| CN102712673A (zh) | 2012-10-03 |
| US9284347B2 (en) | 2016-03-15 |
| EP2526114B1 (de) | 2014-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2492681T3 (es) | Método cromatográfico para purificar proteínas que contienen FC | |
| RU2013156669A (ru) | Промывочный раствор и способ аффинной хроматографии | |
| AR069097A1 (es) | Purificacion de anticuerpos por cromatografia de intercambio cationico | |
| ES2500066T3 (es) | Anticuerpos frente a ferroportina y métodos de uso | |
| CL2012001966A1 (es) | Formulación farmacéutica que comprende entre 100-150 mg/ml de un anticuerpo que se une específicamente al receptor a de il-17 humana, una solución acuosa de un buffer 5-30 mm de ácido glutámico ph 4,5-5,2, prolina 2-4% p/v y polisorbato-20 0,005-0,02% p/v; envase farmacéutico y kit que comprende dicha formulación; y su uso para tratar psoriasis. | |
| ES2524786T3 (es) | Uso de quelantes inmovilizados para purificación de proteínas recombinantes por cromatografía de iones metálicos inmovilizados y método de purificación de proteínas recombinantes | |
| RU2012130151A (ru) | Промывочный раствор и способ промывки для аффинной хроматографии | |
| AR062711A1 (es) | Lavado de arginina en l a purificacion de proteinas usando cromatografia de afinidad | |
| ES2585580T3 (es) | Péptidos novedosos antienvejecimiento y composición cosmética y/o farmacéutica que los contiene | |
| EA201592192A1 (ru) | Способ очистки моноклональных антител | |
| BR112015027812A2 (pt) | processo contínuo de multietapa para purificação de anticorpos | |
| AR097791A1 (es) | Formulaciones de anticuerpos anti-pdl1 | |
| BR112015014751A2 (pt) | anticorpos anti-tau humanos | |
| BR112015022119A2 (pt) | Polipeptídeo, composto conjugado, composição farmacêutica, ácido nucleico, vetor, células hospedeiras procariótica e eucariótica, método de produção de um polipeptídeo, e, método de tratamento | |
| BR112015011749A2 (pt) | controle do uso de um único espaço de estacionamento para múliplos veículos utilizando múltiplas câmeras | |
| AR085138A1 (es) | VARIANTES DE Fc Y METODOS PARA SU PRODUCCION | |
| AR086074A1 (es) | Composiciones y metodo para tratar enfermedades autoinmunes | |
| AR070633A1 (es) | Metodos para modificar el punto isoelectrico de anticuerpos mediante la sustitucion de aminoacidos en la region de determinacion de la complementariedad (cdr) | |
| AR095432A1 (es) | Proteínas de unión a antígeno | |
| CL2013002888A1 (es) | Anticuerpo que se une peptido antigenico que se obtiene a partir de una proteina tau; composicion farmaceutica que comprende; uso para tratar trastorno o enfermedad neurodegenerativa;kit de ensayo, linea celular (div 2457-2011). | |
| AR063840A1 (es) | Anticuerpos humanos monoclonales para btla y metodos de uso | |
| CR9576A (es) | METODOS PARA PURIFICAR PROTEINAS QUE CONTIENE LA REGION Fc | |
| PE20150996A1 (es) | Etanercept correctamente plegado de alta pureza y excelente rendimiento | |
| CL2016001741A1 (es) | Método de purificación de conjugados de anticuerpo-fármaco adc mediante cromatografía de interacción hidrofóbica hic que comprende obtener una mezcla de adc en una solución acuosa de sal de 0,2 a 1,5 m, cargar en una columna de hic, recolectar fracción no unida, lavar, y eluir con una solución acuosa de sal de 0 a 0,1 m. | |
| BRPI0806737A8 (pt) | uso de sistema de renomeação de registrador para encaminhar resultados intermediários entre instruções constituintes de uma instrução expandida |